67 episodes

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

Treating Blood Cancers The Leukemia & Lymphoma Society

    • Science

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

    Strategic Approaches to Pediatric and AYA Survivorship Care

    Strategic Approaches to Pediatric and AYA Survivorship Care

    Karen E. Effinger, MD, MS, Children’s Healthcare of Atlanta, Atlanta, GA

























    Recorded on April 4, 2024











    Karen E. Effinger, MD, MS

    Associate Professor of Pediatrics

    Emory University School of Medicine

    Co-Director, Survivor Program

    Aflac Cancer & Blood Disorders Center, Children’s Healthcare of Atlanta

    Atlanta, GA









    In this episode, Dr. Karen Effinger from Children’s Healthcare of Atlanta, provides a comprehensive overview into survivorship care for pediatric, adolescent, and young adult (AYA) patients. Dr. Effinger discusses long-term effects of treatment, importance of survivorship guidelines, survivorship care plans, and ongoing care management. She also addresses approaches to support survivors and their families to underscore the vital role in optimizing outcomes. Tune in today to hear valuable insights into supporting pediatric and AYA survivors!













    This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.

    • 28 min
    Insights and Updates on Navigating the AML Landscape

    Insights and Updates on Navigating the AML Landscape

    Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX

























    Recorded on March 28, 2024











    Hagop M. Kantarjian, M.D.

    Professor and Chairman, Department of Leukemia

    Samsung Distinguished University Chair in Cancer Medicine

    MD Anderson Cancer Center, University of Texas

    Houston, TX









    Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care.

    Learn more today!

    • 35 min
    CAR T-cell Therapy in 2024

    CAR T-cell Therapy in 2024

    Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO

























    Recorded on March 12, 2024











    Michael Tees, MD, MPH

    Director, Lymphoma Program

    Lymphoma Executive Committee Member, Sarah Cannon Research Institute

    Associate Member, Colorado Blood Cancer Institute

    Denver, CO









    Join Dr. Michael Tees from the Colorado Blood Cancer Institute, as he discusses

    Chimeric antigen receptor (CAR) T-cell therapy in 2024. Dr. Tees provides an overview of immunotherapy and approved indications, how to discuss treatment options with your patients, what to consider when referring patients for CAR T-cell therapy, how to prepare patients, and educating patients and caregivers about toxicity management. He also provides insight into the limitations of CAR-T therapy, as well as future directions. Tune in to this informative episode today to learn more!













    This episode is supported by Bristol Myers Squibb, Johnson & Johnson|Legend Biotech, Kite, a Gilead Company, and Novartis Pharmaceuticals Corporation.

    • 29 min
    Supporting Healthcare Professionals to Reduce Burnout

    Supporting Healthcare Professionals to Reduce Burnout

    Alfred Lee, MD, PhD, Yale University, New Haven, CT

























    Recorded on February 22, 2024











    Alfred Lee, MD, PhD

    Professor of Medicine, Yale School of Medicine

    Program Director, Hematology and Medical Oncology Fellowship

    Chief, Division of Classical Hematology, Yale Cancer Center

    Yale University

    New Haven, CT









    Join us for this important and engaging episode, as Dr. Alfred Lee from Yale University addresses stress and burnout in healthcare professionals. While reflecting on his personal experience, Dr. Lee discusses warning signs, symptoms, risk factors, and strategies and resources to help reduce and prevent burnout. Tune in today!

    • 28 min
    Creating a Roadmap for Adult Survivorship Care

    Creating a Roadmap for Adult Survivorship Care

    Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL

























    Recorded on December 7, 2023











    Meghna Ailawadhi, M.B.B.S., M.D.

    Cancer Survivorship Consultant, Assistant Professor of Medicine

    Department of Hematology/Oncology

    Mayo Clinic

    Jacksonville, FL









    In this episode, Dr. Meghna Ailawadhi from the Mayo Clinic in Jacksonville, FL joins us for a conversation on survivorship care for adults. Dr. Ailawadhi discusses the importance of shared decision-making and coordination with primary care, including strategies to support adherence. She also provides an overview of disparities and challenges in survivorship care, as well as education and support resources for healthcare professionals and survivors. Learn more by listening today!













    This episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Merck & Co. Inc.

    • 26 min
    Highlights from attending the 2023 ASH Annual Meeting

    Highlights from attending the 2023 ASH Annual Meeting

    Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

























    Recorded on December 19, 2023









    Lee Greenberger, PhD

    Chief Scientific Officer and SVP

    The Leukemia & Lymphoma Society

    Rye Brook, NY









    Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to discuss highlights from the 65th American Society of Hematology (ASH) Annual Meeting in December 2023, including updates on blood cancer research, treatment, and clinical trials in leukemia, lymphoma, myeloma, MDS, and MPNs. Tune in to this informative update today!

    • 32 min

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Manasgatha - A Sinhala podcast that dwells into all things interesting including tech, IT, politics
Manasgatha
NASA's Curious Universe
National Aeronautics and Space Administration (NASA)
StarTalk Radio
Neil deGrasse Tyson
Radiolab
WNYC Studios
Relaxing Music For Sleep And Stress Relief
AK Entertainments

You Might Also Like

Two Onc Docs
Sam and Karine
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Short Wave
NPR
The Oncology Nursing Podcast
Oncology Nursing Society
Hidden Brain
Hidden Brain, Shankar Vedantam
Freakonomics Radio
Freakonomics Radio + Stitcher